Overview
- Parents Dennis and Dana Diekmeier say their 14-year-old daughter will be admitted in Würzburg for the IMAZA course starting Monday and monitored in isolation during the active phase.
- During treatment, family members must remain behind glass as the injected radiotracer circulates, according to Dennis Diekmeier's account in interviews.
- A late-November test dose showed visible tracer uptake, which the family described as a hopeful signal after earlier therapies failed.
- Delani has faced a malignant kidney tumor that spread to her lungs, with multiple lung operations and several chemotherapies, and doctors cited in reports have estimated survival odds at about five percent.
- The family plans a quiet Christmas and a possible trip to Austria if her condition allows, acknowledging that the medical response to this therapy will only be clear after the course.